226 related articles for article (PubMed ID: 17483544)
81. The Promiscuity of Squalene Synthase-Like Enzyme: Dehydrosqualene Synthase, a Natural Squalene Hyperproducer?
Guan Z; Song Y; de Vries M; Permentier H; Tepper P; van Merkerk R; Setroikromo R; Quax WJ
J Agric Food Chem; 2024 Feb; 72(6):3017-3024. PubMed ID: 38315649
[TBL] [Abstract][Full Text] [Related]
82. Effect of terbinafine on the biosynthetic pathway of isoprenoid compounds in carrot suspension cultured cells.
Miras-Moreno B; Almagro L; Pedreño MA; Sabater-Jara AB
Plant Cell Rep; 2018 Jul; 37(7):1011-1019. PubMed ID: 29680944
[TBL] [Abstract][Full Text] [Related]
83. 3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors.
Harwood HJ; Barbacci-Tobin EG; Petras SF; Lindsey S; Pellarin LD
Biochem Pharmacol; 1997 Mar; 53(6):839-64. PubMed ID: 9113105
[TBL] [Abstract][Full Text] [Related]
84. Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes.
Rondini EA; Pant A; Kocarek TA
J Pharmacol Exp Ther; 2015 Dec; 355(3):429-41. PubMed ID: 26427720
[TBL] [Abstract][Full Text] [Related]
85. Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway.
Yang YF; Chang YC; Jan YH; Yang CJ; Huang MS; Hsiao M
Oncogenesis; 2020 Aug; 9(8):78. PubMed ID: 32862200
[TBL] [Abstract][Full Text] [Related]
86. Transcriptional regulation of the squalene synthase gene (ERG9) in the yeast Saccharomyces cerevisiae.
Kennedy MA; Barbuch R; Bard M
Biochim Biophys Acta; 1999 Apr; 1445(1):110-22. PubMed ID: 10209263
[TBL] [Abstract][Full Text] [Related]
87. Cloning, solubilization, and characterization of squalene synthase from Thermosynechococcus elongatus BP-1.
Lee S; Poulter CD
J Bacteriol; 2008 Jun; 190(11):3808-16. PubMed ID: 18375558
[TBL] [Abstract][Full Text] [Related]
88. Arabidopsis thaliana contains a single gene encoding squalene synthase.
Busquets A; Keim V; Closa M; del Arco A; Boronat A; Arró M; Ferrer A
Plant Mol Biol; 2008 May; 67(1-2):25-36. PubMed ID: 18236008
[TBL] [Abstract][Full Text] [Related]
89. Total synthesis of the squalene synthase inhibitor zaragozic acid C.
Nakamura S
Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):1-10. PubMed ID: 15635219
[TBL] [Abstract][Full Text] [Related]
90. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
91. In silico study of binding motifs in squalene synthase enzyme of secondary metabolic pathway of solanaceae [corrected].
Sanchita ; Singh G; Sharma A
Mol Biol Rep; 2014 Nov; 41(11):7201-8. PubMed ID: 25106523
[TBL] [Abstract][Full Text] [Related]
92. Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus.
Kahlon AK; Roy S; Sharma A
J Biomol Struct Dyn; 2010 Oct; 28(2):201-10. PubMed ID: 20645653
[TBL] [Abstract][Full Text] [Related]
93. Androgens and the control of lipid metabolism in human prostate cancer cells.
Swinnen JV; Verhoeven G
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):191-8. PubMed ID: 9699873
[TBL] [Abstract][Full Text] [Related]
94. Competitive inhibition of squalene synthetase by squalestatin 1.
Hasumi K; Tachikawa K; Sakai K; Murakawa S; Yoshikawa N; Kumazawa S; Endo A
J Antibiot (Tokyo); 1993 Apr; 46(4):689-91. PubMed ID: 8501015
[No Abstract] [Full Text] [Related]
95. Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential.
Charlton-Menys V; Durrington PN
Drugs; 2007; 67(1):11-6. PubMed ID: 17209661
[TBL] [Abstract][Full Text] [Related]
96. Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration.
Pastar I; Stojadinovic O; Sawaya AP; Stone RC; Lindley LE; Ojeh N; Vukelic S; Samuels HH; Tomic-Canic M
J Cell Physiol; 2016 Nov; 231(11):2452-63. PubMed ID: 26916741
[TBL] [Abstract][Full Text] [Related]
97. Directed optimization of a newly identified squalene synthase from Mortierella alpine based on sequence truncation and site-directed mutagenesis.
Huang D; Yao Y; Zhang H; Mei Z; Wang R; Feng L; Liu B
J Ind Microbiol Biotechnol; 2015 Oct; 42(10):1341-52. PubMed ID: 26275528
[TBL] [Abstract][Full Text] [Related]
98. Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.
Tüzmen Ş; Hostetter G; Watanabe A; Ekmekçi C; Carrigan PE; Shechter I; Kallioniemi O; Miller LJ; Mousses S
Per Med; 2019 Jan; 16(1):51-65. PubMed ID: 30468409
[TBL] [Abstract][Full Text] [Related]
99. Kinetic characterization of squalene synthase from Trypanosoma cruzi: selective inhibition by quinuclidine derivatives.
Sealey-Cardona M; Cammerer S; Jones S; Ruiz-Pérez LM; Brun R; Gilbert IH; Urbina JA; González-Pacanowska D
Antimicrob Agents Chemother; 2007 Jun; 51(6):2123-9. PubMed ID: 17371809
[TBL] [Abstract][Full Text] [Related]
100. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.
Elia J; Carbonnelle D; Logé C; Ory L; Huvelin JM; Tannoury M; Diab-Assaf M; Petit K; Nazih H
Lipids Health Dis; 2019 Sep; 18(1):168. PubMed ID: 31477154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
